Showing results (261-270 of 338) with videos related to

Sort By:
Pageof 34
The American Journal of Surgical Pathology|November 5, 2021
Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined With Multiplex Immunohistochemistry in Diffuse Large B-Cell LymphomaJin Roh, Dok Hyun Yoon, Yoon Kyoung Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2015
Multiple resistant factors in lung cancer with primary resistance to EGFR-TK inhibitors confer poor survivalGo Woon Kim, Joon Seon Song, Chang-Min Choi, et al.
Translational Lung Cancer Research|March 11, 2026
Molecular epidemiology and outcomes of EGFR exon 20 insertion in Korean patients with non-small cell lung cancerShinkyo Yoon, Seong-Eun Kim, Sun Min Lim, et al.
Cellular and Molecular Life Sciences : CMLS|August 20, 2025
MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokinesHyun-Min Ryu, Deokhoon Kim, Jun Young Choi, et al.
Scientific Reports|July 2, 2025
Clinical and histopathological characteristics of melanomas in Asians under age 40Hee Joo Yang, Young Jae Kim, Hyoungmin Na, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non-small Cell Lung CancerHelena A Yu, Luis G Paz-Ares, James Chih-Hsin Yang, et al.
Annals of Hematology|June 25, 2010
Outcome of attempted Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremiaKi-Ho Park, Oh-Hyun Cho, Sang-Oh Lee, et al.
Diagnostic Microbiology and Infectious Disease|March 15, 2011
Development of subsequent bloodstream infection in patients with positive Hickman catheter blood cultures and negative peripheral blood culturesKi-Ho Park, Oh-Hyun Cho, Sang-Oh Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 17, 2020
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 TrialLuis Paz-Ares, Tae Min Kim, David Vicente, et al.
Cancer|January 12, 2021
Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 studyKeunchil Park, Pasi A Jӓnne, Dong-Wan Kim, et al.
Pageof 34